Allianz Asset Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,800
Closed -$246K 2337
2024
Q4
$246K Sell
31,800
-7,500
-19% -$70.4K ﹤0.01% 2057
2024
Q3
$412K Sell
39,300
-53,300
-58% -$650K ﹤0.01% 1904
2024
Q2
$1.08M Buy
+92,600
New +$1.44M ﹤0.01% 1560
2020
Q2
Sell
-15,678
Closed -$508K 2518
2020
Q1
$508K Sell
15,678
-22,724
-59% -$947K ﹤0.01% 2057
2019
Q4
$1.57M Buy
38,402
+22,846
+147% +$902K ﹤0.01% 1981
2019
Q3
$554K Sell
15,556
-85,201
-85% -$3.45M ﹤0.01% 2344
2019
Q2
$5.18M Buy
100,757
+33,944
+51% +$1.69M ﹤0.01% 1490
2019
Q1
$3.83M Buy
66,813
+41,987
+169% +$2.08M ﹤0.01% 1573
2018
Q4
$1.04M Sell
24,826
-65,899
-73% -$3.87M ﹤0.01% 2013
2018
Q3
$6.85M Sell
90,725
-18,780
-17% -$1.35M 0.01% 1418
2018
Q2
$7.86M Buy
109,505
+67,296
+159% +$3.21M 0.01% 1352
2018
Q1
$1.26M Buy
+42,209
New +$1.23M ﹤0.01% 2116

Other funds holding RGNX